INVA
Innoviva Inc
Halal Rating :
Last Price
$18.59
Last updated:
Market Cap
-
7D Change
5.87%
1 Year Change
10.85%
Company Overview
Industries
Exchange
Next Earnings Date
Innoviva, Inc. is a healthcare-focused asset management company that generates revenue primarily through royalty agreements related to respiratory products. The company holds rights to receive royalties on sales of several respiratory products developed through collaborations with GlaxoSmithKline (GSK). Additionally, the company has expanded its portfolio through strategic investments in various healthcare and biotechnology companies.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $89.51m | $87.25m | - | $5.81m | 0.00% | 6.66% |
| June 30, 2024 | $99.9m | $141.68m | - | $5.8m | 0.00% | 4.10% |
| March 31, 2024 | $77.5m | $35.54m | - | $5.85m | 0.00% | 16.46% |
Company Impact
Help us evaluate Innoviva Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.